Debates and Delays Over the Report on Carcinogens

New York Times Op-ed Columnist Nicholas Kristoff writes about the industry’s strategy to lobby Congress against funding for the Report on Carcinogens (RoC).  Roc, published by the National Institute of Health, summarize information about cancer-causing properties of compounds in use today and provides valuable information for regulatory purposes . Recent debates revolve around formaldehyde’s classification […]

In The News: Johnson & Johnson Cleans Up Its Act, Seventh Generation’s Response, and Big Chem

No More Tears: Johnson & Johnson Cleans Up Its Act and Removes Carcinogens Living Green Magazine – August 20, 2012 — Prompted by growing concerns raised by the Campaign for Safe Cosmetics, Johnson & Johnson makers of Aveeno, Neutrogena, and Johnson’s Baby Shampoo, announced today that it will be removing carcinogens and other toxic chemicals from […]

Axe Monitoring Carcinogens?

The American Chemistry Council asks to delay the The National Toxicology Program’s 13th Report on Carcinogens. What is missing in all of this – Integrity. Big dollar lobbying by the ACC has delayed the release of impactful scientific reports for years at the expense of cancer prevention from the carcinogens we are all exposed to.   Attempt […]

In the News: Environmental Estrogens, Water Contamination, and the Risks of Chest Radiation

Women at risk: Health problems linked to environmental estrogens Environmental Health News – July 31, 2012 — Scientists have long suspected a link between hormone-disrupting chemicals in the environment and gynecological diseases. Research investigating these links has had mixed results. Now several new studies are adding to the evidence that some estrogen-mimicking pesticides and industrial chemicals […]

In the News: Radiation Risks, Behind the Pink Ribbon Campaign

Radiation a major risk factor for breast cancer? Food Consumer.org – Sunday July 29, 2012 — Last December a committee of the Institute of Health released a study indicating that medical radiation and hormone-based therapy are two major risk factors for breast cancer for women in the United States… Read More “Pink Ribbons, Inc.” Challenges Cheerful Breast […]